Login / Signup

Retrospective evaluation of patients diagnosed with central precocious puberty who reached the final height.

Kadri YamanEdip UnalAslı BeştaşAmine Aktar KarakayaNurcan BeyazıtBarış Kolbaşı
Published in: Journal of pediatric endocrinology & metabolism : JPEM (2024)
It was found that GnRHa treatment did not have a negative effect on BMI-SDS. It was shown that 94 % of the patients who received GnRHa treatment reached the target height, and in fact, 35.8 % exceeded the target height. A greater final height may be associated with good height-SDS and PAH values on admission.
Keyphrases